P2‐002: Assessment of The Safety, Tolerability, Pharmacokinetics, and Effects on Plasma and Cerebrospinal Fluid AB Peptides of AZD3293, a Novel Bace1 Inhibitor, in Healthy Japanese Adults. (1st July 2016) - Yoshihara, Tatsuya; Sakamoto, Kei; Matsuki, Shunji; Matsuguma, Kyoko; Uchida, Naoki; Azuma, Fumihiko; Russell, Muir; Hughes, Glen; Haeberlein, Samantha Budd; Alexander, Robert C.; Kugler, Alan R.